WEBINAR DETAILS

Proactive vs reactive therapeutic drug monitoring in Inflammatory Bowel Disease (IBD)

Biohit Healthcare Ltd

This webinar will brought together Jimmy Limdi – Consultant Gastroenterologist and Head of the Section for IBD at the Northern Care Alliance NHS Foundation Trust – and Christian Selinger – Consultant Gastroenterologist at Leeds Teaching Hospitals NHS Trust – to discuss proactive versus reactive therapeutic drug monitoring (TDM) for inflammatory bowel disease (IBD). The main discussion was moderated by The Clinical Services Journal, where the two speakers deliberated about the benefits and limitations of using proactive and reactive TDM, with details of their trusts’ practices and case studies.

A live Q&A was held after where attendees could raise any questions.

  • Date
  • Duration

Latest Issues

Scottish Intensive Care Society Conference 2025

Crieff Hydro Hotel, Scotland
1st - 2nd May 2025

AfPP Plymouth Regional Conference

TBC, Plymouth
10th May 2025

Theatres and Decontamination Conference

CBS Arena
20th May 2025

BAUN Day Educational Event

Hilton, Belfast
6th June 2025